BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 31812637)

  • 21. Novel 4-Oxo-4,10-dihydrobenzo[4,5]imidazo[1,2-a]pyrimidine-3-carboxylic Acid Derivatives as HIV-1 Integrase Inhibitors: Synthesis, Docking Studies, Molecular Dynamics Simulation and Biological Activities.
    Zadeh EE; Vahabpour R; Beirami AD; Hajimahdi Z; Zarghi A
    Med Chem; 2021; 17(9):1060-1071. PubMed ID: 32901587
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design, Synthesis, and Biological Evaluations of Hydroxypyridonecarboxylic Acids as Inhibitors of HIV Reverse Transcriptase Associated RNase H.
    Kankanala J; Kirby KA; Liu F; Miller L; Nagy E; Wilson DJ; Parniak MA; Sarafianos SG; Wang Z
    J Med Chem; 2016 May; 59(10):5051-62. PubMed ID: 27094954
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dual inhibitor design for HIV-1 reverse transcriptase and integrase enzymes: a molecular docking study.
    Ercan S; Şenyiğit B; Şenses Y
    J Biomol Struct Dyn; 2020 Feb; 38(2):573-580. PubMed ID: 31787027
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypericum hircinum L. components as new single-molecule inhibitors of both HIV-1 reverse transcriptase-associated DNA polymerase and ribonuclease H activities.
    Esposito F; Sanna C; Del Vecchio C; Cannas V; Venditti A; Corona A; Bianco A; Serrilli AM; Guarcini L; Parolin C; Ballero M; Tramontano E
    Pathog Dis; 2013 Aug; 68(3):116-24. PubMed ID: 23821410
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diketoacid chelating ligands as dual inhibitors of HIV-1 integration process.
    Rogolino D; Carcelli M; Compari C; De Luca L; Ferro S; Fisicaro E; Rispoli G; Neamati N; Debyser Z; Christ F; Chimirri A
    Eur J Med Chem; 2014 May; 78():425-30. PubMed ID: 24704615
    [TBL] [Abstract][Full Text] [Related]  

  • 26. N-Substituted Quinolinonyl Diketo Acid Derivatives as HIV Integrase Strand Transfer Inhibitors and Their Activity against RNase H Function of Reverse Transcriptase.
    Pescatori L; Métifiot M; Chung S; Masoaka T; Cuzzucoli Crucitti G; Messore A; Pupo G; Madia VN; Saccoliti F; Scipione L; Tortorella S; Di Leva FS; Cosconati S; Marinelli L; Novellino E; Le Grice SF; Pommier Y; Marchand C; Costi R; Di Santo R
    J Med Chem; 2015 Jun; 58(11):4610-23. PubMed ID: 25961960
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diketo acids derivatives as dual inhibitors of human immunodeficiency virus type 1 integrase and the reverse transcriptase RNase H domain.
    Di Santo R
    Curr Med Chem; 2011; 18(22):3335-42. PubMed ID: 21728968
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Kuwanon-L as a New Allosteric HIV-1 Integrase Inhibitor: Molecular Modeling and Biological Evaluation.
    Esposito F; Tintori C; Martini R; Christ F; Debyser Z; Ferrarese R; Cabiddu G; Corona A; Ceresola ER; Calcaterra A; Iovine V; Botta B; Clementi M; Canducci F; Botta M; Tramontano E
    Chembiochem; 2015 Nov; 16(17):2507-12. PubMed ID: 26360521
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Wikstroelide M potently inhibits HIV replication by targeting reverse transcriptase and integrase nuclear translocation.
    Zhang X; Huang SZ; Gu WG; Yang LM; Chen H; Zheng CB; Zhao YX; Wan DC; Zheng YT
    Chin J Nat Med; 2014 Mar; 12(3):186-93. PubMed ID: 24702804
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 3-Hydroxypyrimidine-2,4-dione-5-N-benzylcarboxamides Potently Inhibit HIV-1 Integrase and RNase H.
    Wu B; Tang J; Wilson DJ; Huber AD; Casey MC; Ji J; Kankanala J; Xie J; Sarafianos SG; Wang Z
    J Med Chem; 2016 Jul; 59(13):6136-48. PubMed ID: 27283261
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 6-Arylthio-3-hydroxypyrimidine-2,4-diones potently inhibited HIV reverse transcriptase-associated RNase H with antiviral activity.
    Wang L; Tang J; Huber AD; Casey MC; Kirby KA; Wilson DJ; Kankanala J; Xie J; Parniak MA; Sarafianos SG; Wang Z
    Eur J Med Chem; 2018 Aug; 156():652-665. PubMed ID: 30031976
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structure-function analyses unravel distinct effects of allosteric inhibitors of HIV-1 integrase on viral maturation and integration.
    Bonnard D; Le Rouzic E; Eiler S; Amadori C; Orlov I; Bruneau JM; Brias J; Barbion J; Chevreuil F; Spehner D; Chasset S; Ledoussal B; Moreau F; Saïb A; Klaholz BP; Emiliani S; Ruff M; Zamborlini A; Benarous R
    J Biol Chem; 2018 Apr; 293(16):6172-6186. PubMed ID: 29507092
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quinolinonyl Non-Diketo Acid Derivatives as Inhibitors of HIV-1 Ribonuclease H and Polymerase Functions of Reverse Transcriptase.
    Messore A; Corona A; Madia VN; Saccoliti F; Tudino V; De Leo A; Ialongo D; Scipione L; De Vita D; Amendola G; Novellino E; Cosconati S; Métifiot M; Andreola ML; Esposito F; Grandi N; Tramontano E; Costi R; Di Santo R
    J Med Chem; 2021 Jun; 64(12):8579-8598. PubMed ID: 34106711
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evolution of HIV-1 reverse transcriptase and integrase dual inhibitors: Recent advances and developments.
    Gill MSA; Hassan SS; Ahemad N
    Eur J Med Chem; 2019 Oct; 179():423-448. PubMed ID: 31265935
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discovery and Optimization of Novel Pyrazolopyrimidines as Potent and Orally Bioavailable Allosteric HIV-1 Integrase Inhibitors.
    Li G; Meanwell NA; Krystal MR; Langley DR; Naidu BN; Sivaprakasam P; Lewis H; Kish K; Khan JA; Ng A; Trainor GL; Cianci C; Dicker IB; Walker MA; Lin Z; Protack T; Discotto L; Jenkins S; Gerritz SW; Pendri A
    J Med Chem; 2020 Mar; 63(5):2620-2637. PubMed ID: 32081010
    [TBL] [Abstract][Full Text] [Related]  

  • 36. From cycloheptathiophene-3-carboxamide to oxazinone-based derivatives as allosteric HIV-1 ribonuclease H inhibitors.
    Massari S; Corona A; Distinto S; Desantis J; Caredda A; Sabatini S; Manfroni G; Felicetti T; Cecchetti V; Pannecouque C; Maccioni E; Tramontano E; Tabarrini O
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):55-74. PubMed ID: 30362381
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibitors of HIV-1 reverse transcriptase and integrase: classical and emerging therapeutical approaches.
    Tarrago-Litvak L; Andreola ML; Fournier M; Nevinsky GA; Parissi V; de Soultrait VR; Litvak S
    Curr Pharm Des; 2002; 8(8):595-614. PubMed ID: 11945161
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DNA aptamers derived from HIV-1 RNase H inhibitors are strong anti-integrase agents.
    de Soultrait VR; Lozach PY; Altmeyer R; Tarrago-Litvak L; Litvak S; Andréola ML
    J Mol Biol; 2002 Nov; 324(2):195-203. PubMed ID: 12441099
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The HIV-1 integrase-LEDGF allosteric inhibitor MUT-A: resistance profile, impairment of virus maturation and infectivity but without influence on RNA packaging or virus immunoreactivity.
    Amadori C; van der Velden YU; Bonnard D; Orlov I; van Bel N; Le Rouzic E; Miralles L; Brias J; Chevreuil F; Spehner D; Chasset S; Ledoussal B; Mayr L; Moreau F; García F; Gatell J; Zamborlini A; Emiliani S; Ruff M; Klaholz BP; Moog C; Berkhout B; Plana M; Benarous R
    Retrovirology; 2017 Nov; 14(1):50. PubMed ID: 29121950
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Derivatives of 5-nitro-furan-2-carboxylic acid carbamoylmethyl ester inhibit RNase H activity associated with HIV-1 reverse transcriptase.
    Fuji H; Urano E; Futahashi Y; Hamatake M; Tatsumi J; Hoshino T; Morikawa Y; Yamamoto N; Komano J
    J Med Chem; 2009 Mar; 52(5):1380-7. PubMed ID: 19178289
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.